New therapies for type 2 diabetes based on glucagon-like peptide 1

Marzieh Salehi, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

David A. D’Alessio, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

Address: Marzieh Salehi, MD, Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, PO Box 670547, Cincinnati, OH 45267-0547; e-mail [email protected]

Marzieh Salehi, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

David A. D’Alessio, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

Address: Marzieh Salehi, MD, Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, PO Box 670547, Cincinnati, OH 45267-0547; e-mail [email protected]

Marzieh Salehi, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

David A. D’Alessio, MD
Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, Cincinnati, OH

Address: Marzieh Salehi, MD, Division of Endocrinology and Metabolism, University of Cincinnati Medical Center, PO Box 670547, Cincinnati, OH 45267-0547; e-mail [email protected]